BRAF and Miyoshi myopathy: Recently, literature data reported the promising opportunity to combine the inhibition of Aurora A kinase with that of BRAF or MEK in BRAF mutated or wild type MM models [13], while no evidence currently exist testing the combination of Aurora kinases inhibitors with chemotherapy in melanoma treatment.